TriLink BioTechnologies®, a division of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), announced a non-exclusive License ...

SAN DIEGO - TriLink BioTechnologies, a Maravai LifeSciences company (NASDAQ: MRVI), has announced a License and Supply Agreement with Quantoom Biosciences, which will enable the integration of TriLink ...

This acquisition combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and TriLink BioTechnologies' leading drug substance manufacturing capabilities, providing customers ...

SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and global provider of life science reagents and services ...

TriLink’s CleanCap technology produces optimal 5′ cap structures with over 95% efficiency, creating a co-transcriptional capping solution that dramatically improves mRNA yield and process time ...

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology ...

TriLink BioTechnologies, a provider of life science reagents and services, has signed a non-exclusive License and Supply ...

TriLink BioTechnologies & Quantoom Biosciences ink license and supply pact for CleanCap mRNA capping technology: San Diego Wednesday, June 4, 2025, 16:00 Hrs [IST] TriLink BioTech ...

Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions ...